Clinical Trials Browser

Phase 1 × INDUSTRY × GDC-0152 × Clear all

NCT00977067 2017-06-21

A Study of the Safety and Pharmacokinetics of GDC-0152, Administered Intravenously to Patients With Locally Advanced or Metastatic Malignancies

Phase 1 Terminated

Solid Cancers